SILO Stock Overview
Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research.
Notes are coming soon
Silo Pharma, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$2.71|
|52 Week High||US$12.45|
|52 Week Low||US$2.35|
|1 Month Change||5.46%|
|3 Month Change||-27.87%|
|1 Year Change||-71.53%|
|3 Year Change||-86.47%|
|5 Year Change||n/a|
|Change since IPO||-97.70%|
Recent News & Updates
|SILO||US Biotechs||US Market|
Return vs Industry: SILO underperformed the US Biotechs industry which returned 4.5% over the past year.
Return vs Market: SILO underperformed the US Market which returned -8.5% over the past year.
|SILO Average Weekly Movement||13.5%|
|Biotechs Industry Average Movement||12.1%|
|Market Average Movement||6.7%|
|10% most volatile stocks in US Market||17.5%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: SILO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: SILO's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. It is developing solutions to address various underserved conditions.
Silo Pharma, Inc. Fundamentals Summary
|SILO fundamental statistics|
Is SILO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SILO income statement (TTM)|
|Cost of Revenue||US$5.84k|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.05|
|Net Profit Margin||-4,587.04%|
How did SILO perform over the long term?See historical performance and comparison